Rose Crane, CEO of MELA Sciences, will provide a corporate overview at the Craig-Hallum Capital Group's 2014 Alpha Select Conference in New York City.

Crane will discuss the latest FDA Pre-Market Approval of the MelaFind® System.

To learn more go to: www.melafind.com